World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
54
Citations
8300
World Ranking
12828
National Ranking
3394

Paul L. Ornstein publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Paul L. Ornstein sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 157 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Paul L. Ornstein D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Paul L. Ornstein sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 54 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Paul L. Ornstein is affiliated with Eli Lilly and Company in the United States. Their research spans multiple fields within medicine and biochemical sciences, with a focus on molecular biology and infectious diseases among other areas.

Ornstein's work extends to several key fields of study including:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these broader fields, their research covers various subfields such as:

  • Molecular Biology
  • Radiology, Nuclear Medicine and Imaging
  • Oncology
  • Infectious Diseases

The scientist's main topics of research include:

  • Historical Medical Research and Treatments
  • Cancer Treatment and Pharmacology
  • Cancer and biochemical research
  • Tuberculosis Research and Epidemiology
  • Cancer therapeutics and mechanisms
  • Biochemical and Molecular Research

Recent publications authored or co-authored by Paul L. Ornstein include:

  • Novel Trifluoromethyl Pyrimidinone Compounds With Activity Against Mycobacterium tuberculosis, 2021, Frontiers in Chemistry
  • Excellence in Medicinal Chemistry: Celebrating ACS Medicinal Chemistry Division (MEDI) Awards. A Call for Nominations, 2023, ACS Medicinal Chemistry Letters
  • Excellence in Medicinal Chemistry: Celebrating ACS Medicinal Chemistry Division (MEDI) Awards. A Call for Nominations, 2023, Journal of Medicinal Chemistry

The primary publication venues for Ornstein's work are:

  • Frontiers in Chemistry
  • ACS Medicinal Chemistry Letters
  • Journal of Medicinal Chemistry

Paul L. Ornstein has frequently collaborated with the following researchers:

  • María-Jesús Blanco
  • A Bryant-Friedrich
  • Gunda I. Georg
  • Amjad Ali
  • Lori Ferrins

Best Publications

  • A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission

    Vernon R. J. Clarke;Barbara A. Ballyk;Ken H. Hoo;Allan Mandelzys

  • Kainate receptors are involved in synaptic plasticity

    Zuner A. Bortolotto;Vernon R. J. Clarke;Caroline M. Delany;Michael C. Parry

  • LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.

    A.E Kingston;P.L Ornstein;R.A Wright;B.G Johnson

  • A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP.

    Sari E Lauri;Zuner A Bortolotto;David Bleakman;Paul L Ornstein

  • A Role for Ca2+ Stores in Kainate Receptor-Dependent Synaptic Facilitation and LTP at Mossy Fiber Synapses in the Hippocampus

    Sari E Lauri;Zuner A Bortolotto;Robert Nistico;David Bleakman

  • Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat.

    Rosa Maria A. Simmons;Dominic L. Li;Ken H. Hoo;Michelle Deverill

  • Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists.

    Zarrinmayeh H;Nunes Am;Ornstein Pl;Zimmerman Dm

  • Antagonists of GLU K5 -containing kainate receptors prevent pilocarpine-induced limbic seizures

    Ilse Smolders;Zuner A. Bortolotto;Vernon R. J. Clarke;Ruth Warre

  • The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus

    M Vignes;M Vignes;V.R.J Clarke;M.J Parry;D Bleakman

  • The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity

    Stephen M Fitzjohn;Zuner A Bortolotto;MJ Palmer;Andrew J Doherty

  • NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.

    Kurt Rasmussen;Ray W. Fuller;Marsha E. Stockton;Kenneth W. Perry

  • [3H]LY341495 Binding to Group II Metabotropic Glutamate Receptors in Rat Brain

    R A Wright;M B Arnold;W J Wheeler;P L Ornstein

  • Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.

    Michael J O'Neill;Ann Bond;Paul L Ornstein;Mark A Ward

  • Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.

    R Bleakman;D D Schoepp;B Ballyk;H Bufton

  • 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability

    Paul L. Ornstein;Thomas J. Bleisch;M. Brian Arnold;Joseph H. Kennedy

  • [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells

    B G Johnson;R A Wright;M B Arnold;W J Wheeler

  • (3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid : a structurally novel, systemically active, competitive AMPA receptor antagonist

    Ornstein Pl;Arnold Mb;Augenstein Nk;Lodge D

  • Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists.

    Hamideh Zarrinmayeh;Dennis M. Zimmerman;Buddy E. Cantrell;Douglas A. Schober

  • A new method for the efficient conversion of alcohols into iodides via treatment with trimethylsilyl iodide

    Michael E. Jung;Paul L. Ornstein

  • An improved synthesis of homoproline and derivatives

    Robert T. Shuman;Paul L. Ornstein;Jonathan W. Paschal;Paul D. Gesellchen

Frequent Co-Authors

Darryle D. Schoepp
Darryle D. Schoepp Independent Scientist / Consultant, US
David Lodge
David Lodge University of Bristol
David M. Lodge
David M. Lodge Cornell University
Graham L. Collingridge
Graham L. Collingridge Lunenfeld-Tanenbaum Research Institute
Zuner A. Bortolotto
Zuner A. Bortolotto University of Bristol
Smriti Iyengar
Smriti Iyengar Eli Lilly (United States)
Keith A. Wafford
Keith A. Wafford Eli Lilly (United States)
Michael J. O'Neill
Michael J. O'Neill Eli Lilly (United States)
Ilse Smolders
Ilse Smolders Vrije Universiteit Brussel

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA can open doors to a variety of exciting and rewarding careers. For those interested in healthcare, a clear step is to explore how do you become a pharmacist, which involves specialized education and training in pharmaceuticals. This path leverages a strong foundation in chemistry and biology to prepare for patient-centered roles.

On the forensic science side, aspiring professionals should consider education routes like the best online colleges for forensic science. These programs provide essential knowledge in chemical analysis and investigative techniques that are key to careers in criminal justice.

Along these lines, becoming an autopsy technician is a unique career option for those fascinated by anatomy and post-mortem investigations. Learn more about the path by reviewing how to become an autopsy technician, which highlights necessary qualifications and job outlook.

For individuals interested in the psychological aspects of crime and science, pursuing forensic psychology graduate programs online offers flexibility and advanced understanding. These programs blend mental health sciences with investigative skills, fostering diverse career opportunities.

Best Scientists Citing Paul L. Ornstein

Trending Scientists

Recently Published Articles